Navigation Links
Senetek PLC Announces 2008 Annual General Meeting Voting Results
Date:12/17/2008

NAPA, Calif., Dec. 17 /PRNewswire-FirstCall/ -- Senetek PLC (OTC Bulletin Board: SNKTY), a Life Sciences company engaged in the development of technologies that target the science of healthy aging, today announced that shareholders have approved all four resolutions that the Company had proposed at the Annual General Meeting of Shareholders held on December 16, 2008.

"We are pleased with the results of the voting and we thank our shareholders for their support," stated Frank J. Massino, Chairman & CEO of Senetek. "The Board and management of Senetek are looking forward to a productive and successful year in 2009."

About Senetek PLC

Senetek PLC (OTCBB: SNKTY) is a Life Sciences company engaged in the development of breakthrough technologies that target the science of healthy aging. The Company's extensive research collaborations have resulted in a strong pipeline of patented compounds and products with broad therapeutic applications and a leading presence in dermatology. Senetek collaborates with established specialty pharmaceutical companies in the final development and marketing of its proprietary products, most recently resulting in the development of the best-selling anti-aging product sold in the North American physician market. For more information, visit the company's website at http://www.senetekplc.com.

This news release contains statements that may be considered 'forward-looking statements' within the meaning of the Private Securities Litigation Reform Act. Forward-looking statements by their nature involve substantial uncertainty, and actual results may differ materially from those that might be suggested by such statements. Important factors identified by the Company that it believes could result in such material differences are described in the Company's Annual Report on Form 10-K for the year 2007. However, the Company necessarily can give no assurance that it has identified or will identify all of the factors that may result in any particular forward-looking statement materially differing from actual results, and the Company assumes no obligation to correct or update any forward-looking statements which may prove to be inaccurate, whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE Senetek PLC
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Senetek PLC Acquires Rights to Additional Anticancer RNAi Technology
2. Senetek Affirms Strong Financial Position
3. Senetek PLC Reports Second Quarter 2008 Financial Results
4. Senetek PLC Reports First Quarter 2008 Financial Results
5. Senetek PLC Announces Appointments of Key Personnel
6. Senetek PLC in Dispute With Marketer of Pyratine-6(TM)
7. Webcast Alert: Isis Pharmaceuticals Announces That Abbott Exercised Its Option to Acquire Ibis Biosciences
8. Fuld & Company Announces Appointment of MIT Fellow to Head Pharmaceutical Teams Strategic Gaming and Consulting Services
9. ASP Announces Availability of EVOTECH(TM) Endoscope Cleaner and Reprocessor - First Commercially Available System to Eliminate Manual Cleaning of Endoscopes
10. Transcept Pharmaceuticals Announces FDA Acceptance for Review of New Drug Application for Intermezzo(R)
11. Cardiums InnerCool Announces First Patient Treated With New Tissue-Specific UroCool(TM) System in Robotic-Assisted Prostate Surgery Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2016)... -- According to a new market report published ... A Streptococcus (GAS) Nucleic Acid (NA) Test Products Market - ... - 2023 ", the Europe molecular ... test products market was valued at US$ 8.3 Mn in ... 11.6% from 2015 to 2023 to reach US$ 22.3 Mn ...
(Date:5/6/2016)... ... May 06, 2016 , ... ... release, Clinical Studio Version 4.1, greatly improves performance of the platform. In particular, ... often generate tremendous volumes of data to be collected on a per patient ...
(Date:5/5/2016)... ... 2016 , ... Proove Biosciences, Inc. today announced ... diagnostics company. The Algynomics platform and its patient cohorts provide researchers ... chronic pain, which will allow targeted preventive efforts, enhance patient stratification in clinical ...
(Date:5/5/2016)...  Why are two uber-successful former agency presidents ... launching a new venture—yet going about things in a ... helping clients raise the value of their offerings in ... type of collaboration. The result is Elevate, ... medical device sectors. Elevate specializes in shaping and transforming ...
Breaking Biology Technology:
(Date:3/23/2016)... Massachusetts , March 23, 2016 /PRNewswire/ ... im Interesse erhöhter Sicherheit Gesichts- und Stimmerkennung ... Xura, Inc. (NASDAQ: MESG ), ... bekannt, dass das Unternehmen mit SpeechPro zusammenarbeitet, ... aus der Finanzdienstleistungsbranche, wird die Möglichkeit angeboten, ...
(Date:3/17/2016)... , March 17, 2016 ABI ... intelligence, forecasts the global biometrics market will reach ... impressive 118% increase from 2015. Consumer electronics, particularly ... embedded fingerprint sensors anticipated to reach two billion ... Dimitrios Pavlakis , Research Analyst at ...
(Date:3/11/2016)... , March 11, 2016 http://www.apimages.com ) ... Cross reference: Picture is available at AP Images ( http://www.apimages.com ) ... DERMALOG will be used to produce the new refugee identity cards. ... biometric innovations, at CeBIT in Hanover next ... from DERMALOG will be used to produce the new refugee identity ...
Breaking Biology News(10 mins):